跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要直接围绕异质性治疗效应估计、受益子群识别与个体化治疗决策展开。

反馈分类问题

Estimation of Optimal Individualized Treatment Rules Using a Covariate-Specific Treatment Effect Curve With High-Dimensional Covariates

利用高维协变量特异性治疗效应曲线估计最优个体化治疗规则

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Wenchuan Guo
Xiao-Hua Zhou
Shujie Ma

利用高维协变量特异性治疗效应曲线估计最优个体化治疗规则

研究问题
在基线协变量维度很高时,如何估计治疗效应异质性,并将其估计不确定性纳入个体化治疗选择?
方法与思路
作者用稀疏半参数 logistic 单指标系数模型估计协变量权重,再以样条回拟合核方法估计效应曲线及同时置信带。
材料陈述的贡献
摘要称,该方法兼顾降维与灵活建模,并通过渐近达到名义置信水平的同时置信带识别受益子群、量化治疗规则的不确定性。
阅读关注点
应核对效应曲线的目标定义、治疗分配与识别条件、稀疏单指标限制,以及置信带如何转化为具体治疗选择规则。
阅读边界
仅据版本未注明的 OpenAlex 索引摘要;因果识别、稀疏性条件及治疗规则最优性的适用范围未详述,不能推断刊本变化。

原文摘要

With a large number of baseline covariates, we propose a new semiparametric modeling strategy for heterogeneous treatment effect estimation and individualized treatment selection, which are two major goals in personalized medicine. We achieve the first goal through estimating a covariate-specific treatment effect (CSTE) curve modeled as an unknown function of a weighted linear combination of all baseline covariates. The weight or the coefficient for each covariate is estimated by fitting a sparse semiparametric logistic single-index coefficient model. The CSTE curve is estimated by a spline-backfitted kernel procedure, which enables us to further construct a simultaneous confidence band (SCB) for the CSTE curve under a desired confidence level. Based on the SCB, we find the subgroups of patients that benefit from each treatment, so that we can make individualized treatment selection. The innovations of the proposed method are 3-fold. First, the proposed method can quantify variability associated with the estimated optimal individualized treatment rule with high-dimensional covariates. Second, the proposed method is very flexible to depict both local and global associations between the treatment and baseline covariates in the presence of high-dimensional covariates, and thus it enjoys flexibility while achieving dimensionality reduction. Third, the SCB achieves the nominal confidence level asymptotically, and it provides a uniform inferential tool in making individualized treatment decisions. Supplementary materials for this article are available online.

笔记与分组